The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
- 1 October 2005
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (4) , 330-335
- https://doi.org/10.1016/s1081-1206(10)61150-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Aspirin and NSAID sensitivityImmunology and Allergy Clinics of North America, 2004
- Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and managementJournal of Allergy and Clinical Immunology, 2003
- Extending the understanding of leukotrienes in asthmaCurrent Opinion in Allergy and Clinical Immunology, 2003
- The effect of leukotriene‐modifier drugs on aspirin‐induced asthma and rhinitis reactionsClinical and Experimental Allergy, 2002
- Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmaticsAnnals of Allergy, Asthma & Immunology, 2000
- Leukotrienes in RhinitisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Salmeterol Prevents Aspirin-induced Attacks of Asthma and Interferes with Eicosanoid MetabolismAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Theophylline infusion modulates prostaglandin and leukotriene production in manProstaglandins, Leukotrienes & Essential Fatty Acids, 1997
- Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirinJournal of Allergy and Clinical Immunology, 1983